Over the last five years the CHTN provided 235,710 biospecimens to approved researchers throughout the U.S. and Canada as well as a few internationally. In 2016, the CHTN provided 433 IRB reviewed researchers 49,832 quality samples from consented surgical remnant tissues. 72% of the specimens provided were by the researchers primary CHTN division while the remaining 28% of specimens were provided by the CHTN consortium of medical centers.
Special collections are available from some divisions. The Mid-Atlantic Division has an assortment of available tissue microarrays (TMAs). The Pediatric Division can provides samples from the Children’s Oncology Group (COG) and the Eastern, Midwestern, Southern, and Western Divisions add geographic and ethnic diversity to the samples provided.
All CHTN divisions work within the CHTN consortium and network investigator biospecimen requests if agreeable to the investigator to the other CHTN divisions. All Divisions participate to assure best results for the requesting investigator.
The image on the right represents the contributions by all CHTN divisions to investigators in 2016. Please note on the image ED = Eastern Division, MAD = Mid-Atlantic Division, MWD = Midwestern Division, PED = Pediatric Division, SD = Southern Division, WD = Western Division
The full data was presented at the 2017 Cancer Research and Oncology Virtual Conference (CRO) October 10-11, 2017.